BI Asset Management Fondsmaeglerselskab A/S
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1778131
KOBENHAVN, G7
Position in REGN
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$2,502,580
-$2,288,417 QoQ
Shares Held
3,239
-47.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BI Asset Management Fondsmaeglerselskab A/S holds $81,144,167 across 10 Biotechnology names. REGN ranks #7 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,531 | $22,117,572 | |
| 2 | TECH |
BIO-TECHNE Corp
|
316,510 | $16,540,812 | |
| 3 | INCY |
Incyte Corp
|
155,246 | $14,611,753 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
148,752 | $9,613,841 | |
| 5 | EXEL |
Exelixis, Inc.
|
152,320 | $6,533,004 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
81,878 | $5,578,348 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
3,239 | $2,502,580 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,697 | $1,884,966 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,502,580 | 3,239 | Shares | Defined | 2026-04-16 | |
| 2025-12-31 | $4,790,997 | 6,207 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,380,088 | 4,233 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $2,616,600 | 4,984 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,859,108 | 4,508 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $3,290,252 | 4,619 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,492,219 | 3,322 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,365,398 | 3,202 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,599,739 | 4,779 | Shares | Defined | 2024-05-03 | |
| 2023-12-31 | $3,947,035 | 4,494 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $7,795,077 | 9,472 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $14,410,319 | 20,055 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $16,319,187 | 19,861 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $17,739,996 | 24,588 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $11,008,831 | 15,981 | Shares | Defined | 2022-11-07 | |
| 2022-06-30 | $18,721,087 | 31,670 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $21,767,656 | 31,167 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $23,840,511 | 37,751 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $21,144,989 | 34,940 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $4,881,081 | 8,739 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $4,283,336 | 9,053 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $4,331,564 | 8,966 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $4,365,724 | 7,799 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $2,689,178 | 4,312 | Shares | Defined | 2020-08-05 | |
| No filing history on record for this holder in this stock. | ||||||